Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and misoprostol for prevention of blood loss at vaginal delivery
PACTR202507750793530Not yet recruiting
- Sponsor
- self
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin and misoprostol in postpartum hemorrhage (PPH), sponsored by self. Primary endpoint: Mean blood loss during the third stage of labour. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
oxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202507750793530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507750793530.